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Letters to the EditorLIMB ISCHEMIA AND
FEMORAL ARTERIAL
CANNULATION FOR
EXTRACORPOREAL
MEMBRANE OXYGENATION:
DOES THE PERFECT
TECHNIQUE EXIST?
To the Editor:
We read the very interesting report
by Demertzis and Carrel1 presenting
a technique for the transformation
of percutaneous femoral cannulation
to chimney-graft cannulation for
arterial access in extracorporeal
membrane oxygenation (ECMO)
support. They reported a series of 3
patients undergoing venoarterial
ECMO who received percutaneous
cannulation through femoral vessels
and a switch to transprosthetic can-
nulation within the following 24
hours. After surgical preparation of
the common femoral artery, an end-
to-side anastomosis between the
vascular prosthesis and the arterial
vessel was performed proximally to
the insertion of the ECMO cannula.
A new cannula was then inserted
into the prosthesis and the old cannu-
lation site was repaired. No local
complications and no distal ischemia
were described.
According to our experience, the
rate of ischemic complications after
femoral cannulation was 21.4%,2
although the literature shows a varia-
tion between 10% and 70%.3 Periph-
eral arterial disease and a larger
cannula size to body surface area ratio
are the strongest predictors of vascular
complications.4 In order to prevent
ischemic complications, a distal
perfusion cannula is the most common
solution. Otherwise, the chimney-
graft technique is well established
and is particularly recommended in
patients with small vessels, when
ischemia develops after direct arterial
cannulation, or when the groin vessels
are already exposed. Unfortunately,
this approach is not suitable for emer-
gencies. Demertzis and Carrel5 previ-
ously described a techniquewhereby a
presealed vascular prosthesis wasThe Journalplaced over the cannula before direct
cannulation and the vascular pros-
thesis was anastomosed to the artery
after ECMO stabilization. In the latest
report, the authors did not compare the
complications or the outcomes of
both techniques. It would be worth
knowing about any cases of failure
with the previous technique. Further-
more, the new technique requires
more complex handling of the femoral
vessel, which could lead to a higher
risk of arterial dissection or laceration,
thrombosis, embolization, arteriove-
nous fistula, kinking, and infections
of the prosthesis. We wonder if the in-
vestigators checked the site of cannu-
lation during cardiopulmonary bypass
and after weaning from ECMO to note
any local problems.
Moreover, the authors suggested
elective transformation of percuta-
neous cannulation to transprosthetic
cannulation to avoid problems related
to stopcock connection resistance. On
the other hand, total percutaneous can-
nulation could lower wound complica-
tions such as lymphocele, hematoma,
and infections, especially in immuno-
compromised, vasculopathic, obese,
or diabetic patients. Do the investiga-
tors have any suggestions about select-
ing patients suitable for the technique
described?
Demertzis and Carrel1 ought to be
congratulated for the techniques
they described. Such strategies
should be considered as useful surgi-
cal approaches in patients requiring
the switch from percutaneous cannu-
lation to transprosthetic cannulation
such as those with small arteries
occluded by arterial cannulas, with
ischemia after percutaneous cannula-
tion, when distal perfusion catheteri-
zation is not feasible, or distal flow is
inadequate. Our main concern about
the experience presented deals with
the elective nature of transformation
to transprosthetic cannulation. In
response to the question about the
possibility of a perfect technique,
we believe that only an accurate
evaluation of the clinical settingof Thoracic and Cardiovascular Surgerleads to the most appropriate cannu-
lation technique.
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We thank Mariani and colleagues
for their interest, and for their observa-
tions and remarks. Both reports that
Mariani and colleagues refer to1,2 are
technical descriptions of surgical
maneuvers conceived to deal with
distinct clinical situations; they
should not be perceived as clinical
studies. Therefore, any comparison
between them in terms of
complications or outcomes would not
be appropriate.
In the last report,2 we suggest
elective transformation of a percuta-
neous cannulation to a transprosthetic
one as an alternative to a distaly c Volume 147, Number 5 1719
Letters to the Editorperfusion cannula. Generally we agree
with Mariani and colleagues: a full
percutaneous approach can lower can-
nulation site complications, especially
bleeding, during perfusion. However,
in situations where a safe (ie, ultra-
sound or angiographically controlled)
insertion of a distal perfusion cannula
is not possible or if the perfusion pro-
vided by such is not sufficient, the pre-
sented surgical technique can be
helpful.We do not agreewith the state-
ment that the open technique would
bear higher risks for dissection, lacera-
tion, thrombosis, embolization, arte-
riovenous fistula compared with the
percutaneous technique. In our experi-
ence, the contrary is the case. This is
the reason we insist on a safe and
controlled punction and insertion for
both primary and distal perfusion can-
nulas. Infection of the prosthesis could
theoretically be an issue, however the
rather short duration of arteriovenous
perfusion and the subsequent removal
of the long prosthesis minimize this
risk. In any case, the cannulation site
is monitored by standardized clinical
protocols several times a day.
Both techniques described in
our technical reports1,2 should be
perceived as additional elements in the
armamentarium of a cardiovascular
surgeon. The more alternatives we
have, the better we can serve our
patients, especially in critical
situations.
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AGE OFAN ANIMAL BE
CONSIDERED FOR STUDIES ON
POSTCONDITIONING?
To the Editor:
We have read the great article by
Oosterlinck and colleagues,1 which
showed that ischemic postcondition-
ing (IPostC) reduces the infarct size
and left ventricular impairment in
C57BL6/J mice. The protective ef-
fect of IPostC may be reduced in a
mouse model of the obese diabetic
or metabolic syndrome.1 In their
research, the investigators used 3
different types of mice to measure
the short-term effect of IPostC, but
the gender of the animals was not
described. Several studies showed
that the efficacy of IPostC was
different between male and female
mice.2 In addition, because the
infarct size was smaller in female
rats than in male rats under the
same ischemic conditions,3 it might
be confusing to evaluate the effect
of IPostC. Because of this, gender
should be considered in a study for
evaluating IPostC. We believe that
the gender of the mice used in this
study should be given.
The age of an animal can also affect
the IPostC effect.2,3 Even a minor age
difference in the mice from 14 to 16
weeks to 18 to 20 weeks can
negatively affect the outcome of
IPostC.2 Oosterlinck and colleagues1
used mice at 24 weeks to evaluate
the short-term efficacy of IPostC and
mice at 12 weeks for evaluating
long-term effects. We understand
that the purpose of the study was not
to compare the efficacy in the short
term and long term, but we wonder
why the investigators used 2 different
age groups of animals to study the
short-term and long-term effects of
IPostC.
To show the effect of IPostC on left
ventricular remodeling, the investiga-
tors used cine magnetic resonance im-
aging (cMRI). They compared the
results of cMRI between C56BL/6JCardiovascular Surgery c May 2014and DKOmice at 1 and 10 weeks after
ischemia. Because the myocardial
infarction area after ischemia may
differ in individual animals, we
believe that the results of cMRI should
be compared at 1 and 10 weeks in the
same animal. Comparing the results of
cMRI in the same animal at different
times after ischemia would yield
more accurate results without any
bias caused by differences in the
initial size of the myocardial infarc-
tion area.
In conclusion, we ask 3 questions.
First, whether the investigators used
animals of the same gender? Second,
why did the investigators use different
age groups of animals to evaluate the
short-term and long-term effects of
IPostC? Third, did the investigators
compare the cMRI results at different
time intervals in the same animal, not
between the groups?
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